|
|
|
|
| |
|
|
11.93  -0.37 / -3.00%
|
| Thursday, Jul 2, 2009 4:00 PM ET |
Rating:
Buy RIGL
31.67 %
Credit Suisse rated Buy Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) on 07/19/2007, when the stock price was $9.06.
Since then, Rigel Pharmaceuticals, Inc. has gained 31.68% as of 07/02/2009's recent price of $11.93. If you would have followed this Credit Suisse's recommendation on RIGL, you would have gained 31.67% of your investment.
|
|
| Date/Time (ET) | Symbol | Rating | Term | Price (*) | Target |
|
7/19/2007 9:25 AM |
RIGL
|
Buy
|
|
9.06
|
12.00
|
|
|
(*) Stock Price at the time of the recommendation.
|
|
|
|